TCGA-97-8174, TCGA-97-8174SENT_1,"SURGICAL PATHOLOGY REPORT","{SURGICAL,PATHOLOGY,REPORT}","{surgical,pathology,report}","{JJ,NN,NN}","{3,3,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_2,"COLLECTION DATE : ?","{COLLECTION,DATE,:,?}","{COLLECTION,DATE,:,?}","{NNP,NNP,:,CD}","{2,0,0,2}","{}"
TCGA-97-8174, TCGA-97-8174SENT_3,"SPECIIVIENS : 1 .","{SPECIIVIENS,:,1,.}","{SPECIIVIENS,:,1,.}","{NNP,:,CD,.}","{0,0,1,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_4,"F/S R2 LYMPH NODE 2 .","{F/S,R2,LYMPH,NODE,2,.}","{f/s,r2,lymph,node,2,.}","{NN,NN,NN,NN,CD,.}","{4,4,4,0,4,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_5,"F/S R4 LYMPH NODE 3 .","{F/S,R4,LYMPH,NODE,3,.}","{f/s,r4,lymph,node,3,.}","{NN,NN,NN,NN,CD,.}","{4,4,4,0,4,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_6,"F/S L4 LYMPH NODE 4 .","{F/S,L4,LYMPH,NODE,4,.}","{f/s,l4,lymph,node,4,.}","{NN,NN,NN,NN,CD,.}","{4,4,4,0,4,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_7,"F/S LUNG RIGHT UPPER LOBE 5 .","{F/S,LUNG,RIGHT,UPPER,LOBE,5,.}","{f/s,lung,RIGHT,UPPER,LOBE,5,.}","{NN,NN,NNP,NNP,NNP,CD,.}","{2,0,6,6,2,6,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_8,"RIB 5 6 .","{RIB,5,6,.}","{rib,5,6,.}","{NN,CD,CD,.}","{0,3,1,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_9,"STATION 10 LYMPH NODE 7 .","{STATION,10,LYMPH,NODE,7,.}","{station,10,LYMPH,node,7,.}","{NN,CD,NNP,NN,CD,.}","{3,3,0,3,4,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_10,"STATION 11 LYMPH NODE 8 .","{STATION,11,LYMPH,NODE,8,.}","{station,11,lymph,node,8,.}","{NN,CD,NN,NN,CD,.}","{4,4,4,0,4,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_11,"STATION 7 LYMPH NODE 9 .","{STATION,7,LYMPH,NODE,9,.}","{station,7,LYMPH,NODE,9,.}","{NN,CD,NNP,NNP,CD,.}","{4,4,4,0,4,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_12,"CYST WALL SEE ADDENDUM","{CYST,WALL,SEE,ADDENDUM}","{CYST,WALL,see,addendum}","{NNP,NNP,VBP,NNS}","{2,3,0,3}","{}"
TCGA-97-8174, TCGA-97-8174SENT_13,"Reason For Addendum # 1 : Molecular Studies Reason For Addendum # 2 : Molecular Studies Reason For Addendum # 3 : Biomarker Report","{Reason,For,Addendum,#,1,:,Molecular,Studies,Reason,For,Addendum,#,2,:,Molecular,Studies,Reason,For,Addendum,#,3,:,Biomarker,Report}","{reason,for,Addendum,#,1,:,molecular,study,reason,for,Addendum,#,2,:,molecular,study,reason,for,Addendum,#,3,:,Biomarker,Report}","{NN,IN,NNP,#,CD,:,JJ,NNS,NN,IN,NNP,#,CD,:,JJ,NNS,NN,IN,NNP,#,CD,:,NNP,NNP}","{0,1,2,5,3,0,9,9,3,0,9,13,11,0,17,17,3,0,17,21,19,0,24,3}","{}"
TCGA-97-8174, TCGA-97-8174SENT_14,"DIAGNOSIS :","{DIAGNOSIS,:}","{diagnosis,:}","{NN,:}","{0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_15,"1 .","{1,.}","{1,.}","{LS,.}","{0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_16,"LYMPH NODE RIGHT LEVEL 2 : BIOPSY - THREE LYMPH NODES NEGATIVE FOR CARCINOMA ( 0/3 ) .","{LYMPH,NODE,RIGHT,LEVEL,2,:,BIOPSY,-,THREE,LYMPH,NODES,NEGATIVE,FOR,CARCINOMA,(,0/3,),.}","{lymph,node,right,level,2,:,biopsy,-,three,LYMPH,NODES,NEGATIVE,for,CARCINOMA,(,0/3,),.}","{NN,NN,NN,NN,CD,:,NN,:,CD,NNP,NNP,NNP,IN,NNP,CD,CD,NN,.}","{2,0,5,2,5,0,2,0,12,12,8,12,0,14,16,19,14,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_17,"2 .","{2,.}","{2,.}","{LS,.}","{0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_18,"LYMPH NODE RIGHT LEVEL 4 : BIOPSY - THREE LYMPH NODES NEGATIVE FOR CARCINOMA ( 0/3 ) .","{LYMPH,NODE,RIGHT,LEVEL,4,:,BIOPSY,-,THREE,LYMPH,NODES,NEGATIVE,FOR,CARCINOMA,(,0/3,),.}","{lymph,node,right,level,4,:,biopsy,-,three,LYMPH,NODES,NEGATIVE,for,CARCINOMA,(,0/3,),.}","{NN,NN,NN,NN,CD,:,NN,:,CD,NNP,NNP,NNP,IN,NNP,CD,CD,NN,.}","{2,0,5,2,5,0,2,0,12,12,8,12,0,14,16,19,14,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_19,"3 .","{3,.}","{3,.}","{LS,.}","{0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_20,"LYMPH NODE LEFT LEVEL 4 : BIOPSY - TWO LYMPH NODES NEGATIVE FOR CARCINOMA ( 0/2 ) .","{LYMPH,NODE,LEFT,LEVEL,4,:,BIOPSY,-,TWO,LYMPH,NODES,NEGATIVE,FOR,CARCINOMA,(,0/2,),.}","{lymph,node,LEFT,LEVEL,4,:,biopsy,-,two,lymph,node,NEGATIVE,for,CARCINOMA,(,0/2,),.}","{NN,NN,NNP,NNP,CD,:,NN,:,CD,NN,NNS,NNP,IN,NNP,CD,CD,NN,.}","{2,0,5,2,5,0,2,0,12,12,8,2,0,14,16,19,14,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_21,"4 .","{4,.}","{4,.}","{LS,.}","{0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_22,"LUNG RIGHT UPPER LOBE : LOBECTOMY - ADENOCARCINOMA PAPILLARY PREDOMINANT ( 7.0 CM ) SEE NOTE .","{LUNG,RIGHT,UPPER,LOBE,:,LOBECTOMY,-,ADENOCARCINOMA,PAPILLARY,PREDOMINANT,(,7.0,CM,),SEE,NOTE,.}","{lung,RIGHT,UPPER,LOBE,:,lobectomy,-,adenocarcinoma,papillary,predominant,(,7.0,cm,),see,note,.}","{NN,NNP,NNP,NNP,:,NN,:,NN,NN,JJ,CD,CD,NN,NN,VBP,VB,.}","{0,5,5,1,0,1,0,18,9,11,14,16,16,11,1,18,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_23,"- THE BRONCHIAL AND VASCULAR MARGINS ARE FREE OF TUMOR .","{-,THE,BRONCHIAL,AND,VASCULAR,MARGINS,ARE,FREE,OF,TUMOR,.}","{-,the,bronchial,and,vascular,margin,be,free,of,tumor,.}","{:,DT,NN,CC,NN,NNS,VBP,NNS,IN,NN,.}","{0,3,8,0,6,3,8,0,0,8,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_24,"- SIX BENIGN LYMPH NODES ( 0/6 ) .","{-,SIX,BENIGN,LYMPH,NODES,(,0/6,),.}","{-,six,benign,lymph,node,(,0/6,),.}","{:,CD,JJ,NN,VBZ,CD,CD,NN,.}","{0,4,4,5,0,7,8,5,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_25,"Note : The tumor consists of papillary ( 90 % ) lepidic ( 5 % ) and micropapillary ( 5 % ) components .","{Note,:,The,tumor,consists,of,papillary,(,90,%,),lepidic,(,5,%,),and,micropapillary,(,5,%,),components,.}","{note,:,the,tumor,consist,of,papillary,(,90,%,),lepidic,(,5,%,),and,micropapillary,(,5,%,),component,.}","{VB,:,DT,NN,VBZ,IN,JJ,NN,CD,NN,CD,JJ,NN,CD,NN,CD,CC,JJ,NN,CD,NN,CD,NNS,.}","{0,0,4,5,1,0,8,5,10,5,10,14,10,16,14,14,0,20,10,22,20,24,20,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_26,"Results of mutational studies will be reported in addenda .","{Results,of,mutational,studies,will,be,reported,in,addenda,.}","{result,of,mutational,study,will,be,report,in,addendum,.}","{NNS,IN,JJ,NNS,MD,VB,VBN,IN,NN,.}","{7,0,4,1,7,7,0,0,7,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_27,"5 .","{5,.}","{5,.}","{CD,.}","{0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_28,"RIB 5TH : EXCISION - BONE AND BONE MARROW WITH TRILINEAGE HEMATOPOEISIS .","{RIB,5TH,:,EXCISION,-,BONE,AND,BONE,MARROW,WITH,TRILINEAGE,HEMATOPOEISIS,.}","{rib,5th,:,excision,-,bone,and,bone,marrow,with,trilineage,hematopoeisis,.}","{NN,NN,:,NN,:,NN,CC,NN,NN,IN,NN,NNS,.}","{0,1,0,1,0,5,0,10,5,0,13,7,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_29,"6 .","{6,.}","{6,.}","{CD,.}","{0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_30,"LYMPH NODE LEVEL 10 : BIOPSY - TWO LYMPH NODES NEGATIVE FOR CARCINOMA ( 0/2 ) .","{LYMPH,NODE,LEVEL,10,:,BIOPSY,-,TWO,LYMPH,NODES,NEGATIVE,FOR,CARCINOMA,(,0/2,),.}","{lymph,node,level,10,:,biopsy,-,two,lymph,node,NEGATIVE,for,CARCINOMA,(,0/2,),.}","{NN,NN,NN,CD,:,NN,:,CD,NN,NNS,NNP,IN,NNP,CD,CD,NN,.}","{2,0,2,4,0,2,0,11,11,7,2,0,13,15,18,13,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_31,"7 .","{7,.}","{7,.}","{CD,.}","{0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_32,"LYMPH NODE LEVEL 11 : BIOPSY - FIVE LYMPH NODES NEGATIVE FOR CARCINOMA ( 0/5 ) .","{LYMPH,NODE,LEVEL,11,:,BIOPSY,-,FIVE,LYMPH,NODES,NEGATIVE,FOR,CARCINOMA,(,0/5,),.}","{lymph,node,level,11,:,biopsy,-,five,LYMPH,NODES,NEGATIVE,for,CARCINOMA,(,0/5,),.}","{NN,NN,NN,CD,:,NN,:,CD,NNP,NNP,NNP,IN,NNP,CD,CD,NN,.}","{2,0,2,4,0,2,0,11,11,7,2,0,13,15,18,13,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_33,"8 .","{8,.}","{8,.}","{CD,.}","{0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_34,"LYMPH NODE LEVEL 7 : BIOPSY - TEN LYMPH NODES NEGATIVE FOR CARCINOMA ( 0/10 ) .","{LYMPH,NODE,LEVEL,7,:,BIOPSY,-,TEN,LYMPH,NODES,NEGATIVE,FOR,CARCINOMA,(,0/10,),.}","{lymph,node,level,7,:,biopsy,-,ten,lymph,node,NEGATIVE,for,CARCINOMA,(,0/10,),.}","{NN,NN,NN,CD,:,NN,:,CD,NN,NNS,NNP,IN,NNP,CD,CD,NN,.}","{2,0,2,4,0,2,0,11,11,7,2,0,13,15,18,13,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_35,"9 .","{9,.}","{9,.}","{CD,.}","{0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_36,"LUNG CYST : EXCISION - BENIGN FIBROCONNECTIVE TISSUE AND ADIPOSE TISSUE WITH A SINGLE DILATED BRONCHIOLE .","{LUNG,CYST,:,EXCISION,-,BENIGN,FIBROCONNECTIVE,TISSUE,AND,ADIPOSE,TISSUE,WITH,A,SINGLE,DILATED,BRONCHIOLE,.}","{lung,CYST,:,excision,-,benign,fibroconnective,tissue,and,adipose,tissue,with,a,single,dilated,bronchiole,.}","{NN,NNP,:,NN,:,JJ,JJ,NN,CC,NN,NN,IN,DT,JJ,JJ,NN,.}","{0,1,0,1,0,9,9,5,0,12,5,0,17,17,17,9,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_37,"Specimens : 1 : F/S R2 LYMPH NODE : F/S R4 LYMPH NODE : F/S L4 LYMPH NODE : F/S LUNG RIGHT UPPER LOBE : RIB 5 : STATION 10 LYMPH NODE : STATION 11 LYMPH NODE : STATION 7 LYMPH NODE : CYST WALL D ? IO Ul-B0310","{Specimens,:,1,:,F/S,R2,LYMPH,NODE,:,F/S,R4,LYMPH,NODE,:,F/S,L4,LYMPH,NODE,:,F/S,LUNG,RIGHT,UPPER,LOBE,:,RIB,5,:,STATION,10,LYMPH,NODE,:,STATION,11,LYMPH,NODE,:,STATION,7,LYMPH,NODE,:,CYST,WALL,D,?,IO,Ul-B0310}","{specimen,:,1,:,f/s,r2,lymph,node,:,f/s,r4,lymph,node,:,f/s,l4,lymph,node,:,f/s,lung,RIGHT,UPPER,LOBE,:,rib,5,:,station,10,LYMPH,NODE,:,station,11,LYMPH,NODE,:,station,7,LYMPH,NODE,:,CYST,WALL,d,?,IO,ul-b0310}","{NNS,:,CD,:,NN,NN,NN,NN,:,NN,NN,NN,NN,:,NN,NN,NN,NN,:,NN,NN,NNP,NNP,NNP,:,NN,CD,:,NN,CD,NNP,NNP,:,NN,CD,NNP,NNP,:,NN,CD,NNP,NNP,:,NNP,NNP,NN,CD,NNP,NN}","{47,0,1,0,8,8,8,3,0,11,3,13,11,0,16,3,18,16,0,21,3,25,25,21,0,3,27,0,3,30,33,30,0,3,35,38,35,0,3,40,43,40,0,46,1,47,50,50,47}","{}"
TCGA-97-8174, TCGA-97-8174SENT_38,"LUNG : Resection SPECIMEN Specimen : Lobe ( s ) of lung ( specify ) Right upper lobe Procedure : Lobectomy Specimen Integrity : Intact Specimen Laterality : Right Tumor Site : Upper lobe Tumor Focality : Unifocal TUMOR Histologic Type : Adenocarcinoma mixed subtype Histologic Grade : G2 : Moderately differentiated EXTENT Tumor Size : Greatest dimension ( cm ) 7cm Additional Dimension ( cm ) : 6cm X 3.5 cm","{LUNG,:,Resection,SPECIMEN,Specimen,:,Lobe,(,s,),of,lung,(,specify,),Right,upper,lobe,Procedure,:,Lobectomy,Specimen,Integrity,:,Intact,Specimen,Laterality,:,Right,Tumor,Site,:,Upper,lobe,Tumor,Focality,:,Unifocal,TUMOR,Histologic,Type,:,Adenocarcinoma,mixed,subtype,Histologic,Grade,:,G2,:,Moderately,differentiated,EXTENT,Tumor,Size,:,Greatest,dimension,(,cm,),7cm,Additional,Dimension,(,cm,),:,6cm,X,3.5,cm}","{lung,:,Resection,SPECIMEN,Specimen,:,lobe,(,s,),of,lung,(,specify,),Right,upper,lobe,Procedure,:,Lobectomy,Specimen,Integrity,:,Intact,Specimen,Laterality,:,Right,tumor,site,:,Upper,lobe,tumor,focality,:,unifocal,tumor,histologic,type,:,adenocarcinoma,mixed,subtype,histologic,Grade,:,g2,:,moderately,differentiate,EXTENT,tumor,size,:,greatest,dimension,(,cm,),7cm,additional,dimension,(,cm,),:,6cm,x,3.5,cm}","{NN,:,NNP,NNP,NNP,:,NN,CD,NNS,CD,IN,NN,NN,VB,CD,NNP,JJ,NN,NNP,:,NNP,NNP,NNP,:,NNP,NNP,NNP,:,NNP,NN,NN,:,NNP,NN,NN,NN,:,JJ,NN,JJ,NN,:,NN,JJ,NN,JJ,NNP,:,NN,:,RB,VBN,NNP,NN,NN,:,JJS,NN,CD,NN,NN,CD,JJ,NN,CD,NN,NN,:,CD,NN,CD,NN}","{0,0,5,5,1,0,5,9,7,14,0,13,10,1,14,18,18,14,18,0,23,23,19,0,27,27,23,0,31,31,27,0,27,36,36,33,0,39,27,41,39,0,27,48,48,48,43,0,23,0,53,19,56,56,53,0,56,62,62,62,58,65,65,58,68,68,65,0,73,73,73,14}","{}"
TCGA-97-8174, TCGA-97-8174SENT_39,"Visceral Pleura Invasion : Not identi?ed Tumor Extension : Not applicable MARGINS Bronchial Margin Bronchial Margin Involvement by Invasive Carcinoma : Uninvolved by invasive carcinoma Vascular Margin : Uninvolved by invasive carcinoma ACCESSORY FINDINGS Lymph-Vascular Invasion : Not identified STAGE ( pTNM ) TNM Descriptors : Not applicable Primary Tumor ( pT ) : pT2b : Tumor greater than 5 cm but 7 cm or less in greatest dimension Regional Lymph Nodes ( pN ) pNo : No regional lymph node metastasis Number Examined 31 Number Involved o Distant Metastases ( pM ) : Not applicable ADDITIONAL NON-TUMOR Tumor Associated Atelectasis or Obstructive Pneumonitis : Extends to the hilar region but does not involve entire lung","{Visceral,Pleura,Invasion,:,Not,identi?ed,Tumor,Extension,:,Not,applicable,MARGINS,Bronchial,Margin,Bronchial,Margin,Involvement,by,Invasive,Carcinoma,:,Uninvolved,by,invasive,carcinoma,Vascular,Margin,:,Uninvolved,by,invasive,carcinoma,ACCESSORY,FINDINGS,Lymph-Vascular,Invasion,:,Not,identified,STAGE,(,pTNM,),TNM,Descriptors,:,Not,applicable,Primary,Tumor,(,pT,),:,pT2b,:,Tumor,greater,than,5,cm,but,7,cm,or,less,in,greatest,dimension,Regional,Lymph,Nodes,(,pN,),pNo,:,No,regional,lymph,node,metastasis,Number,Examined,31,Number,Involved,o,Distant,Metastases,(,pM,),:,Not,applicable,ADDITIONAL,NON-TUMOR,Tumor,Associated,Atelectasis,or,Obstructive,Pneumonitis,:,Extends,to,the,hilar,region,but,does,not,involve,entire,lung}","{visceral,Pleura,Invasion,:,not,identi?ed,tumor,Extension,:,not,applicable,margin,bronchial,margin,bronchial,margin,involvement,by,Invasive,Carcinoma,:,uninvolved,by,invasive,carcinoma,vascular,margin,:,uninvolve,by,invasive,carcinoma,accessory,finding,lymph-vascular,Invasion,:,not,identify,stage,(,ptnm,),TNM,Descriptors,:,not,applicable,primary,tumor,(,pt,),:,pt2b,:,tumor,greater,than,5,cm,but,7,cm,or,less,in,greatest,dimension,Regional,Lymph,Nodes,(,pn,),pno,:,no,regional,lymph,node,metastasis,number,examine,31,Number,involve,o,distant,metastase,(,pm,),:,not,applicable,additional,non-tumor,tumor,Associated,Atelectasis,or,obstructive,pneumonitis,:,extend,to,the,hilar,region,but,do,not,involve,entire,lung}","{JJ,NNP,NNP,:,RB,VBN,NN,NNP,:,RB,JJ,NNS,JJ,NN,JJ,NN,NN,IN,NNP,NNP,:,JJ,IN,JJ,NN,JJ,NN,:,VBN,IN,JJ,NN,NN,NNS,JJ,NNP,:,RB,VBN,NN,CD,NN,CD,NNP,NNPS,:,RB,JJ,JJ,NN,CD,NN,NN,:,NN,:,NN,JJR,IN,CD,NN,CC,CD,NN,CC,JJR,IN,JJS,NN,NNP,NNP,NNP,CD,NN,CD,NN,:,DT,JJ,NN,NN,NN,NN,VBN,CD,NNP,VBN,NN,JJ,NNS,VBP,NN,CD,:,RB,JJ,JJ,NN,NN,NNP,NNP,CC,JJ,NN,:,NNS,TO,DT,JJ,NN,CC,VBZ,RB,VB,JJ,NN}","{117,117,117,0,117,117,117,117,0,117,117,117,117,117,117,117,117,117,117,117,0,117,117,117,117,117,117,0,117,117,117,117,117,117,117,117,0,117,117,117,117,117,117,117,117,0,117,117,117,117,117,117,117,0,117,0,117,117,117,117,117,117,117,117,117,117,117,117,117,117,117,117,117,117,117,117,0,117,117,117,117,117,117,117,117,117,117,117,117,117,117,117,117,0,117,117,117,117,117,117,117,117,117,117,0,117,117,117,117,117,117,117,117,117,117,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_40,"Pathologist","{Pathologist}","{pathologist}","{NN}","{0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_41,"CLINICAL HISTORY AND PRE ? OPERATIVE DIAGNOSIS :","{CLINICAL,HISTORY,AND,PRE,?,OPERATIVE,DIAGNOSIS,:}","{clinical,history,and,pre,?,OPERATIVE,DIAGNOSIS,:}","{JJ,NN,CC,NN,CD,NNP,NNP,:}","{2,0,0,7,7,7,2,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_42,"eX ? smoker ( 40 pack ? years ) with hX of asbestos exposure now with a 6.1 cm RUL mass .","{eX,?,smoker,(,40,pack,?,years,),with,hX,of,asbestos,exposure,now,with,a,6.1,cm,RUL,mass,.}","{ex,?,smoker,(,40,pack,?,year,),with,hx,of,asbestos,exposure,now,with,a,6.1,cm,rul,mass,.}","{NN,CD,NN,CD,CD,NN,CD,NNS,RB,IN,NN,IN,NN,NN,RB,IN,DT,CD,NN,NN,NN,.}","{0,3,1,5,6,3,8,1,8,0,8,0,14,11,1,0,22,22,22,22,1,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_43,"MACROSCOPIC DESCRIPTION : The specimen is received in nine parts each labeled with the patient 's name .","{MACROSCOPIC,DESCRIPTION,:,The,specimen,is,received,in,nine,parts,each,labeled,with,the,patient,'s,name,.}","{macroscopic,description,:,the,specimen,be,receive,in,nine,part,each,label,with,the,patient,'s,name,.}","{JJ,NN,:,DT,NN,VBZ,VBN,IN,CD,NNS,DT,VBN,IN,DT,NN,POS,NN,.}","{2,0,0,5,7,7,2,0,10,7,7,12,0,16,18,0,13,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_44,"I. Part one is labeled ? R2 lymph node ' .","{I.,Part,one,is,labeled,?,R2,lymph,node,',.}","{i.,Part,one,be,label,?,r2,lymph,node,',.}","{NN,NNP,CD,VBZ,VBN,CD,NN,NN,NN,'',.}","{5,1,2,5,0,9,9,9,5,0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_45,"It consists of three lymph nodes measuring 0.5 X 0.4 X 0.2 cm ( inked blue ) 0.6 X 0.3 X 0.2 cm ( inked green ) and 0.2 X 0.2 X 0.2 cm ( inked black ) .","{It,consists,of,three,lymph,nodes,measuring,0.5,X,0.4,X,0.2,cm,(,inked,blue,),0.6,X,0.3,X,0.2,cm,(,inked,green,),and,0.2,X,0.2,X,0.2,cm,(,inked,black,),.}","{it,consist,of,three,lymph,node,measure,0.5,x,0.4,x,0.2,cm,(,ink,blue,),0.6,x,0.3,x,0.2,cm,(,ink,green,),and,0.2,x,0.2,x,0.2,cm,(,ink,black,),.}","{PRP,VBZ,IN,CD,NN,NNS,VBG,CD,NN,CD,NN,CD,NN,NN,VBN,JJ,NN,CD,NN,CD,NN,CD,NN,NN,VBN,JJ,NN,CC,CD,NN,CD,NN,CD,NN,NN,VBD,JJ,NN,.}","{2,37,0,6,6,2,2,9,7,11,9,14,14,7,14,17,15,20,17,22,20,25,25,14,25,28,26,0,31,26,33,14,36,36,37,0,39,37,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_46,"Entirely submitted for frozen section .","{Entirely,submitted,for,frozen,section,.}","{entirely,submit,for,frozen,section,.}","{RB,VBN,IN,JJ,NN,.}","{2,0,0,5,2,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_47,"2 .","{2,.}","{2,.}","{LS,.}","{0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_48,"Part two is labeled ' R4 lymph node ? .","{Part,two,is,labeled,',R4,lymph,node,?,.}","{Part,two,be,label,',r4,lymph,node,?,.}","{NNP,CD,VBZ,VBN,'',NN,NN,NN,NN,.}","{4,1,4,0,0,9,9,9,4,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_49,"It consists of three lymph nodes measuring 0.7 X 0.2 X 0.2 cm 0.7 X 0.7 X 0.3 cm and 0.5 X 0.3 X 0.2 cm .","{It,consists,of,three,lymph,nodes,measuring,0.7,X,0.2,X,0.2,cm,0.7,X,0.7,X,0.3,cm,and,0.5,X,0.3,X,0.2,cm,.}","{it,consist,of,three,lymph,node,measure,0.7,x,0.2,x,0.2,cm,0.7,x,0.7,x,0.3,cm,and,0.5,x,0.3,x,0.2,cm,.}","{PRP,VBZ,IN,CD,NN,NNS,VBG,CD,NN,CD,NN,CD,NN,CD,NN,CD,NN,CD,NN,CC,CD,NN,CD,NN,CD,NN,.}","{2,0,0,6,6,2,2,9,7,11,20,13,11,16,13,18,20,20,25,0,23,20,25,27,27,7,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_50,"Entirely submitted for frozen section .","{Entirely,submitted,for,frozen,section,.}","{entirely,submit,for,frozen,section,.}","{RB,VBN,IN,JJ,NN,.}","{2,0,0,5,2,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_51,"3 .","{3,.}","{3,.}","{LS,.}","{0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_52,"Part three is labeled ? L4 lymph node ? .","{Part,three,is,labeled,?,L4,lymph,node,?,.}","{Part,three,be,label,?,l4,lymph,node,?,.}","{NNP,CD,VBZ,VBN,CD,NN,NN,NN,NN,.}","{4,1,4,0,7,7,9,9,4,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_53,"It consists of two lymph nodes measuring 0.5 cm and 0.5 cm in greatest dimension .","{It,consists,of,two,lymph,nodes,measuring,0.5,cm,and,0.5,cm,in,greatest,dimension,.}","{it,consist,of,two,lymph,node,measure,0.5,cm,and,0.5,cm,in,greatest,dimension,.}","{PRP,VBZ,IN,CD,NN,NNS,VBG,CD,NN,CC,CD,NN,IN,JJS,NN,.}","{2,0,0,6,6,2,6,9,7,0,12,7,0,15,12,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_54,"Entirely submitted for frozen section .","{Entirely,submitted,for,frozen,section,.}","{entirely,submit,for,frozen,section,.}","{RB,VBN,IN,JJ,NN,.}","{2,0,0,5,2,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_55,"4 .","{4,.}","{4,.}","{LS,.}","{0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_56,"Part four is received fresh labeled ? right upper lobe ' .","{Part,four,is,received,fresh,labeled,?,right,upper,lobe,',.}","{Part,four,be,receive,fresh,label,?,right,upper,lobe,',.}","{NNP,CD,VBZ,VBN,JJ,VBN,RB,JJ,JJ,NN,'',.}","{4,1,4,0,4,4,7,11,11,7,0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_57,"It consists of a lobectomy specimen of right upper lobe of lung weighing 318 grams measuring 16 X 12 X 6 cm .","{It,consists,of,a,lobectomy,specimen,of,right,upper,lobe,of,lung,weighing,318,grams,measuring,16,X,12,X,6,cm,.}","{it,consist,of,a,lobectomy,specimen,of,right,upper,lobe,of,lung,weigh,318,gram,measure,16,x,12,x,6,cm,.}","{PRP,VBZ,IN,DT,JJ,NN,IN,JJ,JJ,NN,IN,NN,VBG,CD,NNS,VBG,CD,NN,CD,NN,CD,NN,.}","{2,0,0,6,6,2,0,10,10,6,0,6,6,16,14,6,20,18,22,18,24,22,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_58,"The pleura appears smooth tan and glistening .","{The,pleura,appears,smooth,tan,and,glistening,.}","{the,pleuron,appear,smooth,tan,and,glistening,.}","{DT,NN,VBZ,JJ,NN,CC,NN,.}","{2,5,5,5,0,0,5,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_59,"There are two staple lines the longest one measuring 15 cm in length and the shortest measures 5 cm in length .","{There,are,two,staple,lines,the,longest,one,measuring,15,cm,in,length,and,the,shortest,measures,5,cm,in,length,.}","{there,be,two,staple,line,the,longest,one,measure,15,cm,in,length,and,the,shortest,measure,5,cm,in,length,.}","{EX,VBP,CD,JJ,NNS,DT,JJS,CD,VBG,CD,NN,IN,NN,CC,DT,JJS,NNS,CD,NN,IN,NN,.}","{2,0,5,5,2,9,9,5,9,12,10,0,12,0,18,18,10,20,18,0,10,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_60,"The staple lines are inked black .","{The,staple,lines,are,inked,black,.}","{the,staple,line,be,ink,black,.}","{DT,NN,NNS,VBP,VBN,JJ,.}","{3,3,5,5,0,5,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_61,"An i1l ? defined nodular tan ? grey white nodule is noted but is previously opened and measures 7 X 6 X 3.5 cm .","{An,i1l,?,defined,nodular,tan,?,grey,white,nodule,is,noted,but,is,previously,opened,and,measures,7,X,6,X,3.5,cm,.}","{a,i1l,?,define,nodular,tan,?,grey,white,nodule,be,note,but,be,previously,open,and,measure,7,x,6,x,3.5,cm,.}","{DT,JJ,NN,VBN,JJ,NN,CD,NN,JJ,NN,VBZ,VBN,CC,VBZ,RB,VBN,CC,VBZ,CD,NN,CD,NN,CD,NN,.}","{3,3,16,0,6,4,10,10,10,12,12,6,0,16,16,4,0,4,20,18,24,24,24,18,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_62,"The distance of the nodule from the bronchial margin is 0.3 cm and from the vascular margin is 0.1 cm .","{The,distance,of,the,nodule,from,the,bronchial,margin,is,0.3,cm,and,from,the,vascular,margin,is,0.1,cm,.}","{the,distance,of,the,nodule,from,the,bronchial,margin,be,0.3,cm,and,from,the,vascular,margin,be,0.1,cm,.}","{DT,NN,IN,DT,NN,IN,DT,JJ,NN,VBZ,CD,NN,CC,IN,DT,JJ,NN,VBZ,CD,NN,.}","{2,12,0,5,2,0,9,9,5,12,12,0,0,12,17,17,14,20,20,17,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_63,"The remaining lung parenchyma appears unremarkable .","{The,remaining,lung,parenchyma,appears,unremarkable,.}","{the,remain,lung,parenchyma,appear,unremarkable,.}","{DT,VBG,NN,NN,VBZ,JJ,.}","{4,4,4,6,6,0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_64,"A single hilar lymph node is identified that measures 2.5 X 2 X 1 cm .","{A,single,hilar,lymph,node,is,identified,that,measures,2.5,X,2,X,1,cm,.}","{a,single,hilar,lymph,node,be,identify,that,measure,2.5,x,2,x,1,cm,.}","{DT,JJ,JJ,NN,NN,VBZ,VBN,WDT,VBZ,CD,NN,CD,NN,CD,NN,.}","{5,5,5,5,7,7,0,9,7,11,9,15,15,15,9,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_65,"Multiple parenchymal lymph nodes are identified .","{Multiple,parenchymal,lymph,nodes,are,identified,.}","{multiple,parenchymal,lymph,node,be,identify,.}","{JJ,JJ,NN,NNS,VBP,VBN,.}","{4,4,4,6,6,0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_66,"A frozen section evaluation is done on the tumor nodule .","{A,frozen,section,evaluation,is,done,on,the,tumor,nodule,.}","{a,frozen,section,evaluation,be,do,on,the,tumor,nodule,.}","{DT,JJ,NN,NN,VBZ,VBN,IN,DT,NN,NN,.}","{4,4,4,6,6,0,0,10,10,6,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_67,"These are the indicated sections are submitted as follows :","{These,are,the,indicated,sections,are,submitted,as,follows,:}","{these,be,the,indicated,section,be,submit,as,follow,:}","{DT,VBP,DT,JJ,NNS,VBP,VBN,IN,VBZ,:}","{5,5,5,5,0,7,5,9,7,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_68,"5 .","{5,.}","{5,.}","{CD,.}","{0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_69,"Part five is labeled ? rib 5 ' .","{Part,five,is,labeled,?,rib,5,',.}","{Part,five,be,label,?,rib,5,',.}","{NNP,CD,VBZ,VBN,JJ,NN,CD,'',.}","{4,1,4,0,4,5,6,0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_70,"It consists of fragments of hemorrhagic rib measuring 1.3 X 1 X 0.7 cm .","{It,consists,of,fragments,of,hemorrhagic,rib,measuring,1.3,X,1,X,0.7,cm,.}","{it,consist,of,fragment,of,hemorrhagic,rib,measure,1.3,x,1,x,0.7,cm,.}","{PRP,VBZ,IN,NNS,IN,JJ,NN,VBG,CD,NN,CD,NN,CD,NN,.}","{2,0,0,8,0,7,4,2,10,12,12,8,14,12,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_71,"The specimen is sectioned .","{The,specimen,is,sectioned,.}","{the,specimen,be,section,.}","{DT,NN,VBZ,VBN,.}","{2,4,4,0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_72,"Representative sections are submitted after decalcification .","{Representative,sections,are,submitted,after,decalcification,.}","{Representative,section,be,submit,after,decalcification,.}","{NNP,NNS,VBP,VBN,IN,NN,.}","{2,4,4,0,0,4,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_73,"6 .","{6,.}","{6,.}","{CD,.}","{0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_74,"Part siX is labeled ? station 10 lymph node ? .","{Part,siX,is,labeled,?,station,10,lymph,node,?,.}","{Part,siX,be,label,?,station,10,lymph,node,?,.}","{NNP,NNP,VBZ,VBN,JJ,NN,CD,NN,NN,NN,.}","{2,4,4,0,10,10,10,10,10,4,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_75,"It consists of two pieces of tan ? red soft tissue measuring 1.5 X 1.5 X 0.5 cm and 1.2 X 0.5 X 0.5 cm .","{It,consists,of,two,pieces,of,tan,?,red,soft,tissue,measuring,1.5,X,1.5,X,0.5,cm,and,1.2,X,0.5,X,0.5,cm,.}","{it,consist,of,two,piece,of,tan,?,red,soft,tissue,measure,1.5,x,1.5,x,0.5,cm,and,1.2,x,0.5,x,0.5,cm,.}","{PRP,VBZ,IN,CD,NNS,IN,NN,CD,JJ,JJ,NN,VBG,CD,NN,CD,NN,CD,NN,CC,CD,NN,CD,NN,CD,NN,.}","{2,0,0,5,2,0,5,11,11,11,2,11,14,12,18,18,16,14,0,21,12,25,25,23,21,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_76,"Entirely submitted .","{Entirely,submitted,.}","{entirely,submit,.}","{RB,VBN,.}","{2,0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_77,"7 .","{7,.}","{7,.}","{CD,.}","{0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_78,"Part seven is labeled ? station 11 lymph node ' .","{Part,seven,is,labeled,?,station,11,lymph,node,',.}","{Part,seven,be,label,?,station,11,lymph,node,',.}","{NNP,CD,VBZ,VBN,JJ,NN,CD,NN,NN,'',.}","{4,1,4,0,9,9,9,9,4,0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_79,"It consists of one piece of tan ? red soft tissue measuring 2.5 X 1.5 X 0.7 cm .","{It,consists,of,one,piece,of,tan,?,red,soft,tissue,measuring,2.5,X,1.5,X,0.7,cm,.}","{it,consist,of,one,piece,of,tan,?,red,soft,tissue,measure,2.5,x,1.5,x,0.7,cm,.}","{PRP,VBZ,IN,CD,NN,IN,NN,CD,JJ,JJ,NN,VBG,CD,NN,CD,NN,CD,NN,.}","{2,0,0,5,2,0,5,11,11,11,2,11,14,12,16,12,18,16,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_80,"Entirely submitted .","{Entirely,submitted,.}","{entirely,submit,.}","{RB,VBN,.}","{2,0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_81,"8 Part eight is labeled ? station 7 lymph node ' .","{8,Part,eight,is,labeled,?,station,7,lymph,node,',.}","{8,part,eight,be,label,?,station,7,lymph,node,',.}","{CD,NN,CD,VBZ,VBN,JJ,NN,CD,NN,NN,'',.}","{2,5,2,5,0,10,10,10,10,5,0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_82,"It consists of a piece of tan ? red soft tissue measuring 2.5 X 2.0 X 1 cm .","{It,consists,of,a,piece,of,tan,?,red,soft,tissue,measuring,2.5,X,2.0,X,1,cm,.}","{it,consist,of,a,piece,of,tan,?,red,soft,tissue,measure,2.5,x,2.0,x,1,cm,.}","{PRP,VBZ,IN,DT,NN,IN,NN,CD,JJ,JJ,NN,VBG,CD,NN,CD,NN,CD,NN,.}","{2,0,0,5,2,0,5,11,11,11,2,11,14,12,16,14,18,16,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_83,"Entirely submitted .","{Entirely,submitted,.}","{entirely,submit,.}","{RB,VBN,.}","{2,0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_84,"9 .","{9,.}","{9,.}","{CD,.}","{0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_85,"Part nine is labeled ? cyst wall ? .","{Part,nine,is,labeled,?,cyst,wall,?,.}","{Part,nine,be,label,?,cyst,wall,?,.}","{NNP,CD,VBZ,VBN,JJ,NN,NN,NN,.}","{4,1,4,0,8,8,8,4,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_86,"It consists of a piece of tan ? red soft tissue measuring 1.5 X 1.0 X 0.3 cm .","{It,consists,of,a,piece,of,tan,?,red,soft,tissue,measuring,1.5,X,1.0,X,0.3,cm,.}","{it,consist,of,a,piece,of,tan,?,red,soft,tissue,measure,1.5,x,1.0,x,0.3,cm,.}","{PRP,VBZ,IN,DT,NN,IN,NN,CD,JJ,JJ,NN,VBG,CD,NN,CD,NN,CD,NN,.}","{2,0,0,5,2,0,5,11,11,11,2,11,14,12,16,12,18,16,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_87,"Entirely submitted .","{Entirely,submitted,.}","{entirely,submit,.}","{RB,VBN,.}","{2,0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_88,"SUMMARY OF SECTIONS : 1A three lymph nodes 2A three lymph nodes 3A two lymph nodes","{SUMMARY,OF,SECTIONS,:,1A,three,lymph,nodes,2A,three,lymph,nodes,3A,two,lymph,nodes}","{summary,of,section,:,1a,three,lymph,node,2a,three,lymph,node,3a,two,lymph,node}","{NN,IN,NNS,:,NN,CD,NN,NNS,NN,CD,NN,NNS,NN,CD,NN,NNS}","{13,0,1,0,3,8,8,5,13,9,13,13,0,16,16,13}","{}"
TCGA-97-8174, TCGA-97-8174SENT_89,"4A frozen section tumor nodule 4B ? 4D staple line 4E vascular margin 4F bronchial margin 4G hilar lymph nodes 4H tumor in relation to bronchus 41 tumor in relation to lung 4 ] tumor with nonnal lung 4K tumor with adjacent bronchus and vessels 4L tumor with adjacent bronchus 4M ? 4O tumor nodule 4P tumor with adjacent normal lung parenchyma 4Q ? 4T tumor nodule 4U parenchymal lymph nodes 4V normal lung parenchyma 5A representative section 6A ? 6B total 7A one lymph node bisected 7B four lymph nodes 7C ? 7D remainder of tissue 8A ? 8B total 9A total","{4A,frozen,section,tumor,nodule,4B,?,4D,staple,line,4E,vascular,margin,4F,bronchial,margin,4G,hilar,lymph,nodes,4H,tumor,in,relation,to,bronchus,41,tumor,in,relation,to,lung,4,],tumor,with,nonnal,lung,4K,tumor,with,adjacent,bronchus,and,vessels,4L,tumor,with,adjacent,bronchus,4M,?,4O,tumor,nodule,4P,tumor,with,adjacent,normal,lung,parenchyma,4Q,?,4T,tumor,nodule,4U,parenchymal,lymph,nodes,4V,normal,lung,parenchyma,5A,representative,section,6A,?,6B,total,7A,one,lymph,node,bisected,7B,four,lymph,nodes,7C,?,7D,remainder,of,tissue,8A,?,8B,total,9A,total}","{4a,frozen,section,tumor,nodule,4b,?,4d,staple,line,4e,vascular,margin,4f,bronchial,margin,4g,hilar,lymph,node,4h,tumor,in,relation,to,bronchus,41,tumor,in,relation,to,lung,4,],tumor,with,nonnal,lung,4k,tumor,with,adjacent,bronchus,and,vessel,4l,tumor,with,adjacent,bronchus,4m,?,4o,tumor,nodule,4p,tumor,with,adjacent,normal,lung,parenchyma,4q,?,4t,tumor,nodule,4u,parenchymal,lymph,node,4v,normal,lung,parenchyma,5a,representative,section,6a,?,6b,total,7a,one,lymph,node,bisect,7b,four,lymph,node,7c,?,7d,remainder,of,tissue,8a,?,8b,total,9a,total}","{NN,JJ,NN,NN,NN,NN,CD,NN,NN,NN,NN,JJ,NN,NN,JJ,NN,NN,JJ,NN,NNS,NN,NN,IN,NN,TO,NN,CD,NN,IN,NN,TO,NN,CD,CD,NN,IN,JJ,NN,NN,NN,IN,JJ,NNS,CC,NNS,NN,NN,IN,JJ,NNS,NN,CD,NN,NN,NN,NN,NN,IN,JJ,JJ,NN,NN,NN,CD,NN,NN,NN,NN,JJ,NN,NNS,NN,JJ,NN,NN,NN,JJ,NN,NN,CD,NN,JJ,NN,CD,NN,NN,VBD,NN,CD,NN,NNS,NN,CD,NN,NN,IN,NN,NN,CD,NN,JJ,NN,NN}","{104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,104,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_90,"SPECIAL PROCEDURES : decalcification","{SPECIAL,PROCEDURES,:,decalcification}","{special,procedure,:,decalcification}","{JJ,NNS,:,NN}","{2,0,0,2}","{}"
TCGA-97-8174, TCGA-97-8174SENT_91,"INTRA ? OPERATIVE CONSULTATION :","{INTRA,?,OPERATIVE,CONSULTATION,:}","{INTRA,?,OPERATIVE,CONSULTATION,:}","{NNP,CD,NNP,NNP,:}","{4,4,4,0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_92,"l. F/S R2 LYMPH NODE : ( Frozen Section ) ? 3 lymph nodes negative for carcinoma","{l.,F/S,R2,LYMPH,NODE,:,(,Frozen,Section,),?,3,lymph,nodes,negative,for,carcinoma}","{l.,f/s,r2,lymph,node,:,(,Frozen,Section,),?,3,lymph,node,negative,for,carcinoma}","{NN,NN,NN,NN,NN,:,CD,NNP,NNP,NN,CD,CD,NN,NNS,JJ,IN,NN}","{5,5,5,5,0,0,10,10,10,14,12,14,14,5,14,0,15}","{}"
TCGA-97-8174, TCGA-97-8174SENT_93,"2 .","{2,.}","{2,.}","{LS,.}","{0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_94,"F/S R4 LYMPH NODE ( Frozen Section ) ? 3 lymph nodes negative for carcinoma","{F/S,R4,LYMPH,NODE,(,Frozen,Section,),?,3,lymph,nodes,negative,for,carcinoma}","{f/s,r4,lymph,node,(,Frozen,Section,),?,3,lymph,node,negative,for,carcinoma}","{NN,NN,NN,NN,CD,NNP,NNP,NN,CD,CD,NN,NNS,JJ,IN,NN}","{8,8,8,8,8,8,8,0,10,12,12,8,12,0,13}","{}"
TCGA-97-8174, TCGA-97-8174SENT_95,"3 .","{3,.}","{3,.}","{LS,.}","{0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_96,"F/S L4 LYMPH NODE : ( Frozen Section )","{F/S,L4,LYMPH,NODE,:,(,Frozen,Section,)}","{f/s,l4,lymph,node,:,(,Frozen,Section,)}","{NN,NN,NN,NN,:,CD,NNP,NNP,NN}","{4,4,4,0,0,9,9,9,4}","{}"
TCGA-97-8174, TCGA-97-8174SENT_97,"? 2 lymph nodes negative for carcinoma","{?,2,lymph,nodes,negative,for,carcinoma}","{?,2,lymph,node,negative,for,carcinoma}","{NN,CD,NN,NNS,JJ,IN,NN}","{0,4,4,1,4,0,5}","{}"
TCGA-97-8174, TCGA-97-8174SENT_98,"Results reported by and repeat ? back provided by","{Results,reported,by,and,repeat,?,back,provided,by}","{result,report,by,and,repeat,?,back,provide,by}","{NNS,VBN,IN,CC,NN,CD,RB,VBN,IN}","{2,0,2,0,2,5,8,5,8}","{}"
TCGA-97-8174, TCGA-97-8174SENT_99,"4 .","{4,.}","{4,.}","{LS,.}","{0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_100,"F/S LUNG RIGHT UPPER LOBE : ( Frozen Section ) ? adenocarcinoma with predominantly papillary features rted b","{F/S,LUNG,RIGHT,UPPER,LOBE,:,(,Frozen,Section,),?,adenocarcinoma,with,predominantly,papillary,features,rted,b}","{f/s,lung,RIGHT,UPPER,LOBE,:,(,Frozen,Section,),?,adenocarcinoma,with,predominantly,papillary,feature,rted,b}","{NN,NN,NNP,NNP,NNP,:,CD,NNP,NNP,NN,NN,NN,IN,RB,JJ,NNS,VBD,NN}","{2,0,6,6,2,0,13,13,13,13,13,2,18,16,17,18,2,18}","{}"
TCGA-97-8174, TCGA-97-8174SENT_101,"Results repo provided by and repeat ? back","{Results,repo,provided,by,and,repeat,?,back}","{result,repo,provide,by,and,repeat,?,back}","{NNS,VBP,VBN,IN,CC,NN,CD,RB}","{2,0,2,3,6,4,8,6}","{}"
TCGA-97-8174, TCGA-97-8174SENT_102,"ADDENDUM # 1 FOR MOLECULAR TESTS :","{ADDENDUM,#,1,FOR,MOLECULAR,TESTS,:}","{ADDENDUM,#,1,for,molecular,test,:}","{NNP,#,CD,IN,NN,NNS,:}","{0,3,1,0,6,3,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_103,"EGFR KRAS and ALK ( FISH ) was sent o ' for patient The test is to be perfonned on tissue from case","{EGFR,KRAS,and,ALK,(,FISH,),was,sent,o,',for,patient,The,test,is,to,be,perfonned,on,tissue,from,case}","{egfr,KRAS,and,ALK,(,fish,),be,send,o,',for,patient,the,test,be,to,be,perfonn,on,tissue,from,case}","{NN,NNP,CC,NNP,CD,NN,NN,VBD,VBN,NN,'',IN,NN,DT,NN,VBZ,TO,VB,VBN,IN,NN,IN,NN}","{10,1,0,3,8,8,3,10,0,10,0,0,10,16,17,14,20,20,17,0,20,0,20}","{}"
TCGA-97-8174, TCGA-97-8174SENT_104,"The case report slides and blocks for the cited accession number were retrieved from archives .","{The,case,report,slides,and,blocks,for,the,cited,accession,number,were,retrieved,from,archives,.}","{the,case,report,slide,and,block,for,the,cite,accession,number,be,retrieve,from,archive,.}","{DT,NN,NN,NNS,CC,VBZ,IN,DT,VBN,NN,NN,VBD,VBN,IN,NNS,.}","{3,3,8,3,8,0,15,13,13,13,15,15,8,0,15,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_105,"The pathologist whose signature appears below reviewed the original pathology report examined candidate H&E slides and selected block 4M appropriate to the specifications of the ordered molecular anal sis .","{The,pathologist,whose,signature,appears,below,reviewed,the,original,pathology,report,examined,candidate,H&E,slides,and,selected,block,4M,appropriate,to,the,specifications,of,the,ordered,molecular,anal,sis,.}","{the,pathologist,whose,signature,appear,below,review,the,original,pathology,report,examine,candidate,h&e,slide,and,select,block,4m,appropriate,to,the,specification,of,the,order,molecular,anal,si,.}","{DT,NN,WP$,NN,VBZ,IN,VBN,DT,JJ,NN,NN,VBN,NN,NN,NNS,CC,VBN,NN,NN,JJ,TO,DT,NNS,IN,DT,VBN,JJ,JJ,NN,.}","{2,0,4,5,2,5,2,11,11,11,7,2,16,16,13,0,7,21,22,19,0,25,22,0,25,27,31,31,28,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_106,"l H&E and 9 unstained slides were prepared and forwarded to where the subject molecular test will be performed .","{l,H&E,and,9,unstained,slides,were,prepared,and,forwarded,to,where,the,subject,molecular,test,will,be,performed,.}","{l,h&e,and,9,unstained,slide,be,prepare,and,forward,to,where,the,subject,molecular,test,will,be,perform,.}","{NN,NN,CC,CD,JJ,NNS,VBD,VBN,CC,VBN,TO,WRB,DT,JJ,JJ,NN,MD,VB,VBN,.}","{8,10,0,6,6,2,8,0,0,8,0,19,16,16,16,19,19,19,8,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_107,"An addendum report will be issued when the results of this molecular test are available .","{An,addendum,report,will,be,issued,when,the,results,of,this,molecular,test,are,available,.}","{a,addendum,report,will,be,issue,when,the,result,of,this,molecular,test,be,available,.}","{DT,NN,NN,MD,VB,VBN,WRB,DT,NNS,IN,DT,JJ,NN,VBP,JJ,.}","{3,3,6,6,6,0,15,9,15,0,13,13,9,15,6,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_108,"Addendum # 1 erformed by","{Addendum,#,1,erformed,by}","{Addendum,#,1,erform,by}","{NNP,#,CD,VBN,IN}","{0,3,1,1,4}","{}"
TCGA-97-8174, TCGA-97-8174SENT_109,"Electronically signed ?","{Electronically,signed,?}","{electronically,sign,?}","{RB,VBN,NN}","{2,0,2}","{}"
TCGA-97-8174, TCGA-97-8174SENT_110,"ADDENDUM # 2 :","{ADDENDUM,#,2,:}","{ADDENDUM,#,2,:}","{NNP,#,CD,:}","{0,3,1,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_111,"MOLECULAR ONCOLOGY","{MOLECULAR,ONCOLOGY}","{molecular,oncology}","{JJ,NN}","{2,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_112,"KRAS MUTATION ANALYSIS","{KRAS,MUTATION,ANALYSIS}","{KRAS,MUTATION,ANALYSIS}","{NNP,NNP,NNP}","{3,3,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_113,"Referring Physicia Body Site : Lung Specimen Type : Slides Clinical Data : Adenocarcinoma","{Referring,Physicia,Body,Site,:,Lung,Specimen,Type,:,Slides,Clinical,Data,:,Adenocarcinoma}","{refer,Physicia,Body,site,:,lung,specimen,type,:,slide,clinical,datum,:,adenocarcinoma}","{VBG,NNP,NNP,NN,:,NN,NN,NN,:,NNS,JJ,NNS,:,NN}","{0,3,1,3,0,3,8,6,0,3,12,10,0,3}","{}"
TCGA-97-8174, TCGA-97-8174SENT_114,"RESULTS : Wild ? type gene .","{RESULTS,:,Wild,?,type,gene,.}","{result,:,Wild,?,type,gene,.}","{NNS,:,NNP,CD,NN,NN,.}","{0,0,1,6,6,3,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_115,"INTERPRETATION : No mutations were identified at codons l2 and 13 of the KRAS gene .","{INTERPRETATION,:,No,mutations,were,identified,at,codons,l2,and,13,of,the,KRAS,gene,.}","{interpretation,:,no,mutation,be,identify,at,codon,l2,and,13,of,the,KRAS,gene,.}","{NN,:,DT,NNS,VBD,VBN,IN,NNS,NN,CC,CD,IN,DT,NNP,NN,.}","{0,0,4,6,6,1,0,9,6,0,6,0,15,15,11,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_116,"COMMENT : Mutations in the KRAS gene are reported to be associated with poor prognosis and resistance to targeted tyrosine kinase inhibitor therapies in patients with non ? small ? cell lung cancer ( NSCLC ) .","{COMMENT,:,Mutations,in,the,KRAS,gene,are,reported,to,be,associated,with,poor,prognosis,and,resistance,to,targeted,tyrosine,kinase,inhibitor,therapies,in,patients,with,non,?,small,?,cell,lung,cancer,(,NSCLC,),.}","{COMMENT,:,mutation,in,the,KRAS,gene,be,report,to,be,associate,with,poor,prognosis,and,resistance,to,target,tyrosine,kinase,inhibitor,therapy,in,patient,with,non,?,small,?,cell,lung,cancer,(,nsclc,),.}","{NNP,:,NNS,IN,DT,NNP,NN,VBP,VBN,TO,VB,VBN,IN,JJ,NN,CC,NN,TO,VBN,NN,NN,NN,NNS,IN,NNS,IN,JJ,JJ,JJ,NN,NN,NN,NN,CD,NN,NN,.}","{0,0,9,0,7,7,3,9,1,12,12,9,0,15,12,0,15,0,37,24,24,24,20,0,24,0,36,36,36,36,36,36,36,36,26,12,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_117,"KRAS mutations occur in 15-30 % of NSCLC patients and are strongly associated with adenocarcinoma and smoking history .","{KRAS,mutations,occur,in,15-30,%,of,NSCLC,patients,and,are,strongly,associated,with,adenocarcinoma,and,smoking,history,.}","{KRAS,mutation,occur,in,15-30,%,of,nsclc,patient,and,be,strongly,associate,with,adenocarcinoma,and,smoking,history,.}","{NNP,NNS,VBP,IN,CD,NN,IN,NN,NNS,CC,VBP,RB,VBN,IN,NN,CC,NN,NN,.}","{2,3,0,0,6,3,0,9,6,0,13,13,3,0,18,0,15,13,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_118,"This assay analyzes codons l2 and 13 in exon 2 of the KRAS gene ; based on the current literature approximately 98 % of mutations are expected to occur in these codons .","{This,assay,analyzes,codons,l2,and,13,in,exon,2,of,the,KRAS,gene,;,based,on,the,current,literature,approximately,98,%,of,mutations,are,expected,to,occur,in,these,codons,.}","{this,assay,analyze,codon,l2,and,13,in,exon,2,of,the,KRAS,gene,;,base,on,the,current,literature,approximately,98,%,of,mutation,be,expect,to,occur,in,these,codon,.}","{DT,NN,VBZ,NNS,NN,CC,CD,IN,NN,CD,IN,DT,NNP,NN,:,VBN,IN,DT,JJ,NN,RB,CD,NN,IN,NNS,VBP,VBN,TO,VB,IN,DT,NNS,.}","{2,3,0,5,3,0,5,0,3,9,0,14,14,9,0,0,28,20,20,28,23,24,28,0,24,28,3,30,28,0,33,30,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_119,"The analytical sensitivity of the assay is approximately 10 % ; thus mutations present in a low percentage of cells may not be detected .","{The,analytical,sensitivity,of,the,assay,is,approximately,10,%,;,thus,mutations,present,in,a,low,percentage,of,cells,may,not,be,detected,.}","{the,analytical,sensitivity,of,the,assay,be,approximately,10,%,;,thus,mutation,present,in,a,low,percentage,of,cell,may,not,be,detect,.}","{DT,JJ,NN,IN,DT,NN,VBZ,RB,CD,NN,:,RB,NNS,JJ,IN,DT,JJ,NN,IN,NNS,MD,RB,VB,VBN,.}","{3,3,10,0,6,3,10,9,10,0,0,24,24,13,0,18,18,14,0,18,24,24,24,10,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_120,"This test is validated for use in identifying KRAS codon 12 and codon 13 mutations in fresh frozen or fonnalin ? fixed paraffin embedded tissue .","{This,test,is,validated,for,use,in,identifying,KRAS,codon,12,and,codon,13,mutations,in,fresh,frozen,or,fonnalin,?,fixed,paraffin,embedded,tissue,.}","{this,test,be,validate,for,use,in,identify,KRAS,codon,12,and,codon,13,mutation,in,fresh,frozen,or,fonnalin,?,fix,paraffin,embedded,tissue,.}","{DT,NN,VBZ,VBN,IN,NN,IN,VBG,NNP,NN,CD,CC,NN,CD,NNS,IN,JJ,JJ,CC,NN,NN,VBN,NN,JJ,NN,.}","{2,4,4,0,0,4,0,4,10,15,10,0,10,15,8,0,19,15,0,23,15,15,27,27,24,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_121,"In particular the test performance has been established in samples of colorectal cancer and non ? small cell lung carcinoma which harbor these mutations although several other tissues are also known to harbor KRAS mutations ( e. g. tumors of pancreas bile duct ovary appendix etc. ) .","{In,particular,the,test,performance,has,been,established,in,samples,of,colorectal,cancer,and,non,?,small,cell,lung,carcinoma,which,harbor,these,mutations,although,several,other,tissues,are,also,known,to,harbor,KRAS,mutations,(,e.,g.,tumors,of,pancreas,bile,duct,ovary,appendix,etc.,),.}","{in,particular,the,test,performance,have,be,establish,in,sample,of,colorectal,cancer,and,non,?,small,cell,lung,carcinoma,which,harbor,these,mutation,although,several,other,tissue,be,also,know,to,harbor,KRAS,mutation,(,e.,g.,tumor,of,pancreas,bile,duct,ovary,appendix,etc.,),.}","{IN,JJ,DT,NN,NN,VBZ,VBN,VBN,IN,NNS,IN,JJ,NN,CC,JJ,JJ,JJ,NN,NN,NN,WDT,VBP,DT,NNS,IN,JJ,JJ,NNS,VBP,RB,VBN,TO,VB,NNP,NNS,CD,NN,NN,NNS,IN,NN,NN,NN,NN,NN,FW,FW,.}","{0,8,5,5,8,8,8,0,0,8,0,13,10,0,20,20,20,20,20,10,22,20,24,22,32,29,29,32,32,32,8,34,32,36,40,40,40,40,34,0,40,45,42,42,42,52,42,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_122,"Analysis of EGFR mutation or gene amplification status may provide additional infonnation regarding this patient 's probability of response to targeted tyrosine kinase inhibitor therapies if clinically indicated .","{Analysis,of,EGFR,mutation,or,gene,amplification,status,may,provide,additional,infonnation,regarding,this,patient,'s,probability,of,response,to,targeted,tyrosine,kinase,inhibitor,therapies,if,clinically,indicated,.}","{analysis,of,egfr,mutation,or,gene,amplification,status,may,provide,additional,infonnation,regard,this,patient,'s,probability,of,response,to,target,tyrosine,kinase,inhibitor,therapy,if,clinically,indicate,.}","{NN,IN,NN,NN,CC,NN,NN,NN,MD,VB,JJ,NN,VBG,DT,NN,POS,NN,IN,NN,TO,VBN,NN,NN,NN,NNS,IN,RB,VBN,.}","{10,0,4,1,0,8,8,4,10,0,12,10,0,15,17,0,12,0,17,0,10,25,25,25,21,29,29,21,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_123,"See references .","{See,references,.}","{see,reference,.}","{VB,NNS,.}","{0,1,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_124,"METHOD/LIMITATIONS : Tissue sections are reviewed by a pathologist and relevant tumor is selected for analysis .","{METHOD/LIMITATIONS,:,Tissue,sections,are,reviewed,by,a,pathologist,and,relevant,tumor,is,selected,for,analysis,.}","{METHOD/LIMITATIONS,:,tissue,section,be,review,by,a,pathologist,and,relevant,tumor,be,select,for,analysis,.}","{NNP,:,NN,NNS,VBP,VBN,IN,DT,NN,CC,JJ,NN,VBZ,VBN,IN,NN,.}","{0,0,4,6,6,1,0,9,6,0,12,14,14,6,0,14,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_125,"DNA is isolated from the sample quantified and amplified by polymerase chain reaction ( PCR ) using primers to exon 2 of the KRAS gene .","{DNA,is,isolated,from,the,sample,quantified,and,amplified,by,polymerase,chain,reaction,(,PCR,),using,primers,to,exon,2,of,the,KRAS,gene,.}","{dna,be,isolate,from,the,sample,quantify,and,amplify,by,polymerase,chain,reaction,(,pcr,),use,primer,to,exon,2,of,the,KRAS,gene,.}","{NN,VBZ,VBN,IN,DT,NN,VBN,CC,VBN,IN,NN,NN,NN,CD,NN,NN,VBG,NNS,TO,NN,CD,IN,DT,NNP,NN,.}","{10,3,0,0,6,3,3,0,3,0,17,17,17,17,17,10,17,18,0,18,21,0,26,26,21,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_126,"PCR products are subjected to single nucleotide primer extension to detect mutations at codons l2 and 13 ; primer extension products are analyzed using capillary gel electrophoresis and ?uorescence detection .","{PCR,products,are,subjected,to,single,nucleotide,primer,extension,to,detect,mutations,at,codons,l2,and,13,;,primer,extension,products,are,analyzed,using,capillary,gel,electrophoresis,and,?uorescence,detection,.}","{pcr,product,be,subject,to,single,nucleotide,primer,extension,to,detect,mutation,at,codon,l2,and,13,;,primer,extension,product,be,analyze,use,capillary,gel,electrophoresis,and,?uorescence,detection,.}","{NN,NNS,VBP,VBN,TO,JJ,NN,NN,NN,TO,VB,NNS,IN,NNS,NN,CC,CD,:,NN,NN,NNS,VBP,VBN,VBG,JJ,NN,NN,CC,NN,NN,.}","{2,4,4,0,0,9,9,9,4,11,4,11,0,15,11,0,11,0,21,21,23,23,4,23,27,27,24,0,30,27,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_127,"False positive or negative results may occur for reasons that include genetic variants or somatic heterogeneity of the tissue sample .","{False,positive,or,negative,results,may,occur,for,reasons,that,include,genetic,variants,or,somatic,heterogeneity,of,the,tissue,sample,.}","{false,positive,or,negative,result,may,occur,for,reason,that,include,genetic,variant,or,somatic,heterogeneity,of,the,tissue,sample,.}","{JJ,JJ,CC,JJ,NNS,MD,VB,IN,NNS,WDT,VBP,JJ,NNS,CC,JJ,NN,IN,DT,NN,NN,.}","{5,5,0,2,7,7,0,0,7,11,9,13,11,0,16,13,0,20,20,16,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_128,"REFERENCES : E","{REFERENCES,:,E}","{reference,:,e}","{NNS,:,NN}","{0,0,1}","{}"
TCGA-97-8174, TCGA-97-8174SENT_129,"This test was develo ed and its erfonnance characteristics detennined b The laboratory is re ulated under the Clinical Laboratory Improvement Amendments of ( CLIA ) as qualified to perfonn high complexity clinical testing .","{This,test,was,develo,ed,and,its,erfonnance,characteristics,detennined,b,The,laboratory,is,re,ulated,under,the,Clinical,Laboratory,Improvement,Amendments,of,(,CLIA,),as,qualified,to,perfonn,high,complexity,clinical,testing,.}","{this,test,be,develo,ed,and,its,erfonnance,characteristic,detennine,b,the,laboratory,be,re,ulate,under,the,clinical,laboratory,improvement,amendment,of,(,clium,),as,qualify,to,perfonn,high,complexity,clinical,testing,.}","{DT,NN,VBD,JJ,NN,CC,PRP$,NN,NNS,VBD,NN,DT,NN,VBZ,JJ,VBN,IN,DT,JJ,NN,NN,NNS,IN,CD,NN,RB,IN,VBN,TO,VB,JJ,NN,JJ,NN,.}","{2,5,5,5,0,0,9,9,10,5,10,13,15,15,11,15,0,20,20,16,22,16,0,25,22,16,0,34,30,28,32,30,34,16,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_130,"This particular test is not considered a stand along test and should be used only in the context of other diagnostic tests or clinical work ? up related to treatment decisions .","{This,particular,test,is,not,considered,a,stand,along,test,and,should,be,used,only,in,the,context,of,other,diagnostic,tests,or,clinical,work,?,up,related,to,treatment,decisions,.}","{this,particular,test,be,not,consider,a,stand,along,test,and,should,be,use,only,in,the,context,of,other,diagnostic,test,or,clinical,work,?,up,related,to,treatment,decision,.}","{DT,JJ,NN,VBZ,RB,VBN,DT,NN,IN,NN,CC,MD,VB,VBN,RB,IN,DT,NN,IN,JJ,JJ,NNS,CC,JJ,NN,RB,RB,JJ,TO,NN,NNS,.}","{3,3,14,6,6,0,8,6,0,8,0,14,14,6,14,0,18,14,0,22,22,18,0,25,27,25,28,6,0,31,28,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_131,"Electronically signed by : Date :","{Electronically,signed,by,:,Date,:}","{electronically,sign,by,:,date,:}","{RB,VBN,IN,:,NN,:}","{2,0,2,0,3,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_132,"Testin erformed at","{Testin,erformed,at}","{Testin,erform,at}","{NNP,VBD,IN}","{2,0,2}","{}"
TCGA-97-8174, TCGA-97-8174SENT_133,"EGFR Mutation Analysis","{EGFR,Mutation,Analysis}","{egfr,mutation,analysis}","{NN,NN,NN}","{0,3,1}","{}"
TCGA-97-8174, TCGA-97-8174SENT_134,"Referring Physician : Body","{Referring,Physician,:,Body}","{refer,physician,:,body}","{VBG,NN,:,NN}","{0,1,0,2}","{}"
TCGA-97-8174, TCGA-97-8174SENT_135,"Site : Lung","{Site,:,Lung}","{site,:,lung}","{NN,:,NN}","{0,0,1}","{}"
TCGA-97-8174, TCGA-97-8174SENT_136,"Clinical Data : Adenocarcinoma","{Clinical,Data,:,Adenocarcinoma}","{clinical,datum,:,adenocarcinoma}","{JJ,NNS,:,NN}","{2,0,0,2}","{}"
TCGA-97-8174, TCGA-97-8174SENT_137,"RESULTS : No mutation detected .","{RESULTS,:,No,mutation,detected,.}","{result,:,no,mutation,detect,.}","{NNS,:,DT,NN,VBN,.}","{0,0,4,1,4,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_138,"INTERPRETATION : No mutations were identified in the sample provided for analysis .","{INTERPRETATION,:,No,mutations,were,identified,in,the,sample,provided,for,analysis,.}","{interpretation,:,no,mutation,be,identify,in,the,sample,provide,for,analysis,.}","{NN,:,DT,NNS,VBD,VBN,IN,DT,NN,VBN,IN,NN,.}","{0,0,4,6,6,1,0,9,6,9,0,10,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_139,"Fewer than 5 % of non ? small cell lung carcinoma patients without identifiable mutations are reported to be responsive to EGFR tyrosine kinase inhibitor therapies .","{Fewer,than,5,%,of,non,?,small,cell,lung,carcinoma,patients,without,identifiable,mutations,are,reported,to,be,responsive,to,EGFR,tyrosine,kinase,inhibitor,therapies,.}","{fewer,than,5,%,of,non,?,small,cell,lung,carcinoma,patient,without,identifiable,mutation,be,report,to,be,responsive,to,egfr,tyrosine,kinase,inhibitor,therapy,.}","{JJR,IN,CD,NN,IN,JJ,JJ,JJ,NN,NN,NN,NNS,IN,JJ,NNS,VBP,VBN,TO,VB,JJ,TO,NN,NN,NN,NN,NNS,.}","{17,0,4,1,0,12,12,12,12,12,12,4,0,15,12,17,0,20,20,17,0,26,26,26,26,20,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_140,"COMMENT : Forty percent ( 40 % ) or more tumor cellularity is optimal for this mutation analysis .","{COMMENT,:,Forty,percent,(,40,%,),or,more,tumor,cellularity,is,optimal,for,this,mutation,analysis,.}","{COMMENT,:,forty,percent,(,40,%,),or,more,tumor,cellularity,be,optimal,for,this,mutation,analysis,.}","{NNP,:,CD,NN,CD,CD,NN,CD,CC,JJR,NN,NN,VBZ,JJ,IN,DT,NN,NN,.}","{0,0,4,14,7,7,4,4,0,4,12,8,14,1,0,18,18,14,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_141,"The sample submitted showed 30 % tumor cellularity upon pathologist review .","{The,sample,submitted,showed,30,%,tumor,cellularity,upon,pathologist,review,.}","{the,sample,submit,show,30,%,tumor,cellularity,upon,pathologist,review,.}","{DT,NN,VBN,VBD,CD,NN,NN,NN,IN,NN,NN,.}","{2,4,2,0,6,8,8,4,0,11,4,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_142,"A frequently occurring sequence change 236lG > A ( Q787Q ) was identified .","{A,frequently,occurring,sequence,change,236lG,>,A,(,Q787Q,),was,identified,.}","{a,frequently,occur,sequence,change,236lg,>,a,(,q787q,),be,identify,.}","{DT,RB,VBG,NN,NN,NN,JJR,DT,CD,NN,NN,VBD,VBN,.}","{6,3,6,6,6,0,6,11,11,11,13,13,7,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_143,"This polymorphism is known not to have clinical significance .","{This,polymorphism,is,known,not,to,have,clinical,significance,.}","{this,polymorphism,be,know,not,to,have,clinical,significance,.}","{DT,NN,VBZ,VBN,RB,TO,VB,JJ,NN,.}","{2,4,4,0,7,7,4,9,7,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_144,"Mutations in the tyrosine domain of the epidennal growth factor receptor ( EGFR ) gene are reported to be associated with differential responsiveness or resistance to EGFR tyrosine kinase inhibitor ( TKI ) therapies .","{Mutations,in,the,tyrosine,domain,of,the,epidennal,growth,factor,receptor,(,EGFR,),gene,are,reported,to,be,associated,with,differential,responsiveness,or,resistance,to,EGFR,tyrosine,kinase,inhibitor,(,TKI,),therapies,.}","{mutation,in,the,tyrosine,domain,of,the,epidennal,growth,factor,receptor,(,egfr,),gene,be,report,to,be,associate,with,differential,responsiveness,or,resistance,to,egfr,tyrosine,kinase,inhibitor,(,tkus,),therapy,.}","{NNS,IN,DT,NN,NN,IN,DT,JJ,NN,NN,NN,CD,NN,NN,NN,VBP,VBN,TO,VB,VBN,IN,JJ,NN,CC,NN,TO,NN,NN,NN,NN,NN,NN,CD,NNS,.}","{17,0,5,5,1,0,11,11,11,11,5,15,15,15,11,17,0,20,20,17,0,23,20,0,23,0,32,32,32,32,32,20,34,32,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_145,"The objective response rate among patients with a sensitizing mutation ranges from 55 to 82 % .","{The,objective,response,rate,among,patients,with,a,sensitizing,mutation,ranges,from,55,to,82,%,.}","{the,objective,response,rate,among,patient,with,a,sensitize,mutation,range,from,55,to,82,%,.}","{DT,JJ,NN,NN,IN,NNS,IN,DT,VBG,NN,NNS,IN,CD,TO,CD,NN,.}","{4,4,4,0,0,4,0,11,11,11,6,0,15,15,16,11,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_146,"This assay analyzes exons 18-21 of the EGFR tyrosine kinase domain ; based on the current literature most mutations in non ? small ? cell lung carcinoma ( NSCLC ) are expected to occur in these exons .","{This,assay,analyzes,exons,18-21,of,the,EGFR,tyrosine,kinase,domain,;,based,on,the,current,literature,most,mutations,in,non,?,small,?,cell,lung,carcinoma,(,NSCLC,),are,expected,to,occur,in,these,exons,.}","{this,assay,analyze,exon,18-21,of,the,egfr,tyrosine,kinase,domain,;,base,on,the,current,literature,most,mutation,in,non,?,small,?,cell,lung,carcinoma,(,nsclc,),be,expect,to,occur,in,these,exon,.}","{DT,NN,VBZ,NNS,CD,IN,DT,NN,NN,NN,NN,:,VBN,IN,DT,JJ,NN,JJS,NNS,IN,JJ,JJ,JJ,NN,NN,NN,NN,CD,NN,NN,VBP,VBN,TO,VB,IN,DT,NNS,.}","{2,3,0,3,4,0,11,11,11,11,4,0,0,33,17,17,33,20,17,0,28,28,28,28,28,28,20,31,31,33,33,3,35,33,0,38,35,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_147,"Mutations present in less than 10-20 % of extracted DNA may not be detected by this method .","{Mutations,present,in,less,than,10-20,%,of,extracted,DNA,may,not,be,detected,by,this,method,.}","{mutation,present,in,less,than,10-20,%,of,extract,dna,may,not,be,detect,by,this,method,.}","{NNS,JJ,IN,JJR,IN,CD,NN,IN,VBN,NN,MD,RB,VB,VBN,IN,DT,NN,.}","{14,1,0,5,6,7,2,0,10,7,14,14,14,0,0,17,14,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_148,"Mutation status in a sample may change during tumor progression or the course of therapy ; therefore this result can not be used to infer the presence or absence of a mutation in another sample or sub ? sample obtained from this tumor .","{Mutation,status,in,a,sample,may,change,during,tumor,progression,or,the,course,of,therapy,;,therefore,this,result,can,not,be,used,to,infer,the,presence,or,absence,of,a,mutation,in,another,sample,or,sub,?,sample,obtained,from,this,tumor,.}","{mutation,status,in,a,sample,may,change,during,tumor,progression,or,the,course,of,therapy,;,therefore,this,result,can,not,be,use,to,infer,the,presence,or,absence,of,a,mutation,in,another,sample,or,sub,?,sample,obtain,from,this,tumor,.}","{NN,NN,IN,DT,NN,MD,VB,IN,NN,NN,CC,DT,NN,IN,NN,:,RB,DT,NN,MD,RB,VB,VBN,TO,VB,DT,NN,CC,NN,IN,DT,NN,IN,DT,NN,CC,NN,CD,NN,VBN,IN,DT,NN,.}","{2,7,0,5,2,7,0,0,10,7,0,13,10,0,13,0,24,20,24,24,24,24,7,26,24,28,26,0,28,0,33,28,0,36,33,0,40,40,33,40,0,44,41,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_149,"This test is validated for non ? small cell lung carcinoma .","{This,test,is,validated,for,non,?,small,cell,lung,carcinoma,.}","{this,test,be,validate,for,non,?,small,cell,lung,carcinoma,.}","{DT,NN,VBZ,VBN,IN,JJ,JJ,JJ,NN,NN,NN,.}","{2,4,4,0,0,11,11,11,11,11,4,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_150,"The clinical significance and utility of this test in other tumor types is unknown .","{The,clinical,significance,and,utility,of,this,test,in,other,tumor,types,is,unknown,.}","{the,clinical,significance,and,utility,of,this,test,in,other,tumor,type,be,unknown,.}","{DT,JJ,NN,CC,NN,IN,DT,NN,IN,JJ,NN,NNS,VBZ,JJ,.}","{3,3,14,0,14,0,8,3,0,12,12,8,14,0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_151,"METHOD/LIMITATION :","{METHOD/LIMITATION,:}","{METHOD/LIMITATION,:}","{NNP,:}","{0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_152,"Tissue sections are reviewed by a pathologist and relevant tumor is selected for analysis .","{Tissue,sections,are,reviewed,by,a,pathologist,and,relevant,tumor,is,selected,for,analysis,.}","{tissue,section,be,review,by,a,pathologist,and,relevant,tumor,be,select,for,analysis,.}","{NN,NNS,VBP,VBN,IN,DT,NN,CC,JJ,NN,VBZ,VBN,IN,NN,.}","{2,4,4,0,0,7,4,0,10,12,12,4,0,12,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_153,"DNA is isolated from the samples quantified and amplified by polymerase chain reaction ( PCR ) using primers to eXons 18-21 of the EGFR gene .","{DNA,is,isolated,from,the,samples,quantified,and,amplified,by,polymerase,chain,reaction,(,PCR,),using,primers,to,eXons,18-21,of,the,EGFR,gene,.}","{dna,be,isolate,from,the,sample,quantify,and,amplify,by,polymerase,chain,reaction,(,pcr,),use,primer,to,eXons,18-21,of,the,egfr,gene,.}","{NN,VBZ,VBN,IN,DT,NNS,VBN,CC,VBN,IN,NN,NN,NN,CD,NN,NN,VBG,NNS,TO,NNPS,CD,IN,DT,NN,NN,.}","{3,3,0,0,6,3,6,0,6,0,17,17,17,17,17,10,17,18,0,18,8,0,26,26,22,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_154,"PCR products are analyzed by bi ? directional direct DNA sequencing using capillary gel electrophoresis and ?uorescence detection .","{PCR,products,are,analyzed,by,bi,?,directional,direct,DNA,sequencing,using,capillary,gel,electrophoresis,and,?uorescence,detection,.}","{pcr,product,be,analyze,by,bus,?,directional,direct,dna,sequencing,use,capillary,gel,electrophoresis,and,?uorescence,detection,.}","{NN,NNS,VBP,VBN,IN,NN,CD,JJ,JJ,NN,NN,VBG,JJ,NN,NN,CC,NN,NN,.}","{2,4,4,0,0,4,11,11,11,11,4,11,15,15,12,0,18,12,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_155,"False positive or negative results may occur for reasons that include genetic variants or somatic heterogeneity of the tissue sample .","{False,positive,or,negative,results,may,occur,for,reasons,that,include,genetic,variants,or,somatic,heterogeneity,of,the,tissue,sample,.}","{false,positive,or,negative,result,may,occur,for,reason,that,include,genetic,variant,or,somatic,heterogeneity,of,the,tissue,sample,.}","{JJ,JJ,CC,JJ,NNS,MD,VB,IN,NNS,WDT,VBP,JJ,NNS,CC,JJ,NN,IN,DT,NN,NN,.}","{5,5,0,2,7,7,0,0,7,11,9,13,11,0,16,13,0,20,20,16,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_156,"DISCLAIMER : This test was develoied and its perfonnance characteristics detennined b It has not been cleared or approved by the US Food and Drug Administration .","{DISCLAIMER,:,This,test,was,develoied,and,its,perfonnance,characteristics,detennined,b,It,has,not,been,cleared,or,approved,by,the,US,Food,and,Drug,Administration,.}","{DISCLAIMER,:,this,test,be,develoi,and,its,perfonnance,characteristic,detennine,b,it,have,not,be,clear,or,approve,by,the,US,Food,and,Drug,Administration,.}","{NNP,:,DT,NN,VBD,VBN,CC,PRP$,NN,NNS,VBD,NN,PRP,VBZ,RB,VBN,VBN,CC,VBN,IN,DT,NNP,NNP,CC,NNP,NNP,.}","{0,0,4,6,6,1,0,10,10,11,1,11,19,17,17,17,12,0,17,0,23,23,17,0,26,17,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_157,"The FDA has determined that such clearance or approval is not necessary .","{The,FDA,has,determined,that,such,clearance,or,approval,is,not,necessary,.}","{the,FDA,have,determine,that,such,clearance,or,approval,be,not,necessary,.}","{DT,NNP,VBZ,VBN,IN,JJ,NN,CC,NN,VBZ,RB,JJ,.}","{2,4,4,0,12,7,12,0,12,12,12,4,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_158,"This test is used for clinical purposes .","{This,test,is,used,for,clinical,purposes,.}","{this,test,be,use,for,clinical,purpose,.}","{DT,NN,VBZ,VBN,IN,JJ,NNS,.}","{2,4,4,0,0,7,4,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_159,"It should not be regarded as investigation or for research .","{It,should,not,be,regarded,as,investigation,or,for,research,.}","{it,should,not,be,regard,as,investigation,or,for,research,.}","{PRP,MD,RB,VB,VBN,IN,NN,CC,IN,NN,.}","{5,5,5,5,5,0,5,0,0,5,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_160,"The laboratory is regulated under the Clinical Laboratory Improvement Amendments of 2 CLIA ) as qualified to perfonn high complexity clinical testing .","{The,laboratory,is,regulated,under,the,Clinical,Laboratory,Improvement,Amendments,of,2,CLIA,),as,qualified,to,perfonn,high,complexity,clinical,testing,.}","{the,laboratory,be,regulate,under,the,clinical,laboratory,improvement,amendment,of,2,clium,),as,qualify,to,perfonn,high,complexity,clinical,testing,.}","{DT,NN,VBZ,VBN,IN,DT,JJ,NN,NN,NNS,IN,CD,NN,RB,IN,VBN,TO,VB,JJ,NN,JJ,NN,.}","{2,4,4,0,0,10,10,10,10,4,0,13,10,4,0,22,18,16,20,18,22,4,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_161,"This particular test is not considered a stand alone test and should be used only in the context of other diagnostic tests or clinical work ? up related to treatment decisions .","{This,particular,test,is,not,considered,a,stand,alone,test,and,should,be,used,only,in,the,context,of,other,diagnostic,tests,or,clinical,work,?,up,related,to,treatment,decisions,.}","{this,particular,test,be,not,consider,a,stand,alone,test,and,should,be,use,only,in,the,context,of,other,diagnostic,test,or,clinical,work,?,up,related,to,treatment,decision,.}","{DT,JJ,NN,VBZ,RB,VBN,DT,NN,RB,NN,CC,MD,VB,VBN,RB,IN,DT,NN,IN,JJ,JJ,NNS,CC,JJ,NN,RB,RB,JJ,TO,NN,NNS,.}","{3,3,14,6,6,0,10,10,10,6,0,14,14,6,14,0,18,14,0,22,22,18,0,25,27,25,28,6,0,31,28,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_162,"Electronicall si ned by :","{Electronicall,si,ned,by,:}","{Electronicall,si,ned,by,:}","{NNP,FW,FW,IN,:}","{0,3,1,3,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_163,"Addendum # 2 erformed by f","{Addendum,#,2,erformed,by,f}","{Addendum,#,2,erform,by,f}","{NNP,#,CD,VBN,IN,SYM}","{0,3,1,1,1,5}","{}"
TCGA-97-8174, TCGA-97-8174SENT_164,"ADDENDUM 3 :","{ADDENDUM,3,:}","{ADDENDUM,3,:}","{NNP,CD,:}","{0,1,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_165,"Fluorescence In .","{Fluorescence,In,.}","{fluorescence,in,.}","{NN,IN,.}","{0,1,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_166,"? .","{?,.}","{?,.}","{NN,.}","{0,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_167,"Situ Hybridization ( FISH )","{Situ,Hybridization,(,FISH,)}","{Situ,hybridization,(,fish,)}","{NNP,NN,CD,NN,NN}","{0,5,5,5,1}","{}"
TCGA-97-8174, TCGA-97-8174SENT_168,"Referring Physicia Body Site : Lung Clinical Data : Adenocarcinoma","{Referring,Physicia,Body,Site,:,Lung,Clinical,Data,:,Adenocarcinoma}","{refer,Physicia,Body,site,:,lung,clinical,datum,:,adenocarcinoma}","{VBG,NNP,NNP,NN,:,NN,JJ,NNS,:,NN}","{0,4,4,1,0,8,8,4,0,8}","{}"
TCGA-97-8174, TCGA-97-8174SENT_169,"INTERPRETATION : Negative for a rearrangement involving the ALK gene .","{INTERPRETATION,:,Negative,for,a,rearrangement,involving,the,ALK,gene,.}","{interpretation,:,negative,for,a,rearrangement,involve,the,alk,gene,.}","{NN,:,JJ,IN,DT,NN,VBG,DT,NN,NN,.}","{0,0,1,0,6,3,6,10,10,7,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_170,"Probe #Nuclei Examined % Positive Nuclei % Control values 2p23 ( ALK ) V 100 O < l5 .0 A total of 100 cells were scored .","{Probe,#Nuclei,Examined,%,Positive,Nuclei,%,Control,values,2p23,(,ALK,),V,100,O,<,l5,.0,A,total,of,100,cells,were,scored,.}","{probe,#nuclei,examine,%,positive,nucleus,%,control,value,2p23,(,ALK,),V,100,o,<,l5,.0,a,total,of,100,cell,be,score,.}","{NN,NN,VBN,NN,JJ,NNS,NN,NN,NNS,VBP,CD,NNP,CD,NNP,CD,NN,JJR,CD,NN,DT,NN,IN,CD,NNS,VBD,VBN,.}","{2,10,2,3,9,9,9,9,4,0,16,16,16,16,16,19,19,19,10,21,26,0,24,21,26,19,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_171,"FINDINGS : FISH was perfonned on paraffin embedded tissue sections using dual color break ? apart probe ( Abbott Molecular ) to the ALK gene at 2p23 .","{FINDINGS,:,FISH,was,perfonned,on,paraffin,embedded,tissue,sections,using,dual,color,break,?,apart,probe,(,Abbott,Molecular,),to,the,ALK,gene,at,2p23,.}","{finding,:,fish,be,perfonn,on,paraffin,embedded,tissue,section,use,dual,color,break,?,apart,probe,(,Abbott,molecular,),to,the,alk,gene,at,2p23,.}","{NNS,:,NN,VBD,VBN,IN,NN,JJ,NN,NNS,VBG,JJ,NN,NN,CD,RB,NN,CD,NNP,JJ,NN,TO,DT,NN,NN,IN,CD,.}","{0,0,5,5,1,0,10,10,10,5,5,13,14,11,16,19,19,19,14,21,19,0,25,25,19,0,14,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_172,"This probe ?anks the entire gene .","{This,probe,?anks,the,entire,gene,.}","{this,probe,?anks,the,entire,gene,.}","{DT,NN,VBZ,DT,JJ,NN,.}","{2,3,0,6,6,3,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_173,"If a rearrangement involving ALK is present inversion or translocation one of the two probe signals separates as one red ( orange ) and one green signal .","{If,a,rearrangement,involving,ALK,is,present,inversion,or,translocation,one,of,the,two,probe,signals,separates,as,one,red,(,orange,),and,one,green,signal,.}","{if,a,rearrangement,involve,ALK,be,present,inversion,or,translocation,one,of,the,two,probe,signal,separate,as,one,red,(,orange,),and,one,green,signal,.}","{IN,DT,NN,VBG,NNP,VBZ,JJ,NN,CC,NN,CD,IN,DT,CD,NN,NNS,VBZ,IN,CD,JJ,NN,NN,NN,CC,CD,JJ,NN,.}","{7,3,7,0,3,7,19,19,0,19,9,0,18,18,18,13,0,0,25,25,25,25,19,0,29,29,19,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_174,"In this specimen separated signals were present in 0.5 % of the nuclei scored .","{In,this,specimen,separated,signals,were,present,in,0.5,%,of,the,nuclei,scored,.}","{in,this,specimen,separated,signal,be,present,in,0.5,%,of,the,nucleus,score,.}","{IN,DT,NN,JJ,NNS,VBD,JJ,IN,CD,NN,IN,DT,NNS,VBD,.}","{0,3,8,6,8,8,0,0,11,8,0,14,11,14,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_175,"Based on laboratory validation data these results are within the nonnal limits .","{Based,on,laboratory,validation,data,these,results,are,within,the,nonnal,limits,.}","{base,on,laboratory,validation,datum,these,result,be,within,the,nonnal,limit,.}","{VBN,IN,NN,NN,NNS,DT,NNS,VBP,IN,DT,JJ,NNS,.}","{0,9,5,5,9,8,9,0,0,13,13,9,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_176,"COMMENTS : Three to four copies of ALK were observed in 27.0 % of cells .","{COMMENTS,:,Three,to,four,copies,of,ALK,were,observed,in,27.0,%,of,cells,.}","{comment,:,three,to,four,copy,of,ALK,be,observe,in,27.0,%,of,cell,.}","{NNS,:,CD,TO,CD,NNS,IN,NNP,VBD,VBN,IN,CD,NN,IN,NNS,.}","{0,0,5,5,6,10,0,6,10,1,0,13,10,0,13,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_177,"This gain of intact ALK fusion hybridization signals represents an aneuploid population with extra copies of chromosomes 2/2p ALK region .","{This,gain,of,intact,ALK,fusion,hybridization,signals,represents,an,aneuploid,population,with,extra,copies,of,chromosomes,2/2p,ALK,region,.}","{this,gain,of,intact,alk,fusion,hybridization,signal,represent,a,aneuploid,population,with,extra,copy,of,chromosome,2/2p,alk,region,.}","{DT,NN,IN,JJ,NN,NN,NN,NNS,VBZ,DT,JJ,NN,IN,JJ,NNS,IN,NNS,JJ,NN,NN,.}","{2,9,0,8,8,8,8,2,0,12,12,9,0,15,9,0,20,20,20,15,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_178,"Additional copies of ALK are not uncommon in NSCLCs although the significance of extra co ies of the ALK gene in lun? carcinoma is unclear at this time (","{Additional,copies,of,ALK,are,not,uncommon,in,NSCLCs,although,the,significance,of,extra,co,ies,of,the,ALK,gene,in,lun?,carcinoma,is,unclear,at,this,time,(}","{additional,copy,of,ALK,be,not,uncommon,in,nsclc,although,the,significance,of,extra,co,ie,of,the,alk,gene,in,lun?,carcinoma,be,unclear,at,this,time,(}","{JJ,NNS,IN,NNP,VBP,RB,JJ,IN,NNS,IN,DT,NN,IN,JJ,NN,NNS,IN,DT,NN,NN,IN,JJ,NN,VBZ,JJ,IN,DT,NN,NN}","{2,7,0,2,7,7,0,0,7,26,13,26,0,17,17,13,0,21,21,17,0,24,21,26,7,0,30,30,26}","{}"
TCGA-97-8174, TCGA-97-8174SENT_179,"ISCN RESULTS : nuc ish ( ALKx3 4 ) [ 27 / 100 ]","{ISCN,RESULTS,:,nuc,ish,(,ALKx3,4,),[,27,/,100,]}","{ISCN,result,:,nuc,ish,(,alkx3,4,),[,27,/,100,]}","{NNP,NNS,:,NN,NN,CD,NN,CD,CD,NN,CD,:,CD,CD}","{9,1,0,5,2,7,9,9,14,9,10,14,14,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_180,"This test was deVelo ed and its erfonnance characteristics detennined b It has not been cleared or approved by the US Food and Drug Administration .","{This,test,was,deVelo,ed,and,its,erfonnance,characteristics,detennined,b,It,has,not,been,cleared,or,approved,by,the,US,Food,and,Drug,Administration,.}","{this,test,be,deVelo,ed,and,its,erfonnance,characteristic,detennine,b,it,have,not,be,clear,or,approve,by,the,US,Food,and,Drug,Administration,.}","{DT,NN,VBD,NNP,VBD,CC,PRP$,NN,NNS,VBD,NN,PRP,VBZ,RB,VBN,VBN,CC,VBN,IN,DT,NNP,NNP,CC,NNP,NNP,.}","{2,4,4,0,4,0,9,9,10,4,10,16,16,16,16,11,0,16,0,22,22,16,0,25,16,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_181,"The FDA has detennined that such clearance or approval is not necessary .","{The,FDA,has,detennined,that,such,clearance,or,approval,is,not,necessary,.}","{the,FDA,have,detennine,that,such,clearance,or,approval,be,not,necessary,.}","{DT,NNP,VBZ,VBN,IN,JJ,NN,CC,NN,VBZ,RB,JJ,.}","{2,4,4,0,12,7,12,0,12,12,12,4,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_182,"This test is used for clinical purposes .","{This,test,is,used,for,clinical,purposes,.}","{this,test,be,use,for,clinical,purpose,.}","{DT,NN,VBZ,VBN,IN,JJ,NNS,.}","{2,4,4,0,0,7,4,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_183,"It should not be regarded as investigational or for research .","{It,should,not,be,regarded,as,investigational,or,for,research,.}","{it,should,not,be,regard,as,investigational,or,for,research,.}","{PRP,MD,RB,VB,VBN,IN,JJ,CC,IN,NN,.}","{5,5,5,5,5,0,5,0,0,5,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_184,"The laboratory is regulated under the Clinical Laboratory Improvement Amendments of ICLIA ) as qualified to perfonn high complexity clinical testing .","{The,laboratory,is,regulated,under,the,Clinical,Laboratory,Improvement,Amendments,of,ICLIA,),as,qualified,to,perfonn,high,complexity,clinical,testing,.}","{the,laboratory,be,regulate,under,the,clinical,laboratory,improvement,amendment,of,iclium,),as,qualify,to,perfonn,high,complexity,clinical,testing,.}","{DT,NN,VBZ,VBN,IN,DT,JJ,NN,NN,NNS,IN,NN,CD,IN,VBN,TO,VB,JJ,NN,JJ,NN,.}","{2,4,4,0,0,10,10,10,10,4,0,10,12,0,21,17,15,19,17,21,4,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_185,"Electronicall","{Electronicall}","{electronicall}","{NN}","{0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_186,"Addendum # 3 ierformed by Electronically signed The electronic signature attests that the named Attending Pathologist has evaluated the specimen referred to in the signed section of the report and fonnulated the diagnosis therein .","{Addendum,#,3,ierformed,by,Electronically,signed,The,electronic,signature,attests,that,the,named,Attending,Pathologist,has,evaluated,the,specimen,referred,to,in,the,signed,section,of,the,report,and,fonnulated,the,diagnosis,therein,.}","{Addendum,#,3,ierform,by,electronically,sign,the,electronic,signature,attest,that,the,name,attend,pathologist,have,evaluate,the,specimen,refer,to,in,the,sign,section,of,the,report,and,fonnulate,the,diagnosis,therein,.}","{NNP,#,CD,VBN,IN,RB,VBN,DT,JJ,NN,VBZ,IN,DT,VBN,VBG,NN,VBZ,VBN,DT,NN,VBD,TO,IN,DT,VBN,NN,IN,DT,NN,CC,VBD,DT,NN,RB,.}","{31,3,11,3,0,7,4,10,10,7,1,18,18,13,14,15,18,11,20,18,0,21,0,26,26,21,0,29,26,0,21,33,31,31,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_187,"This report may include one or more immunohistochemical stain results that use analyte specific reagents .","{This,report,may,include,one,or,more,immunohistochemical,stain,results,that,use,analyte,specific,reagents,.}","{this,report,may,include,one,or,more,immunohistochemical,stain,result,that,use,analyte,specific,reagent,.}","{DT,NN,MD,VB,CD,CC,JJR,JJ,VB,NNS,WDT,VBP,NN,JJ,NNS,.}","{2,4,4,0,8,0,8,9,4,9,12,10,15,15,12,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_188,"The tests were developed and their performance characteristics detennined by ] Department of Pathology .","{The,tests,were,developed,and,their,performance,characteristics,detennined,by,],Department,of,Pathology,.}","{the,test,be,develop,and,they,performance,characteristic,detennine,by,],Department,of,Pathology,.}","{DT,NNS,VBD,VBN,CC,PRP$,NN,NNS,VBN,IN,NNP,NNP,IN,NNP,.}","{2,4,4,0,0,8,8,9,4,0,12,9,0,12,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_189,"They have not been cleared or approved by the US Food and Drug Administration .","{They,have,not,been,cleared,or,approved,by,the,US,Food,and,Drug,Administration,.}","{they,have,not,be,clear,or,approve,by,the,US,Food,and,Drug,Administration,.}","{PRP,VBP,RB,VBN,VBN,CC,VBN,IN,DT,NNP,NNP,CC,NNP,NNP,.}","{7,5,5,5,0,0,5,0,11,11,5,0,14,5,0}","{}"
TCGA-97-8174, TCGA-97-8174SENT_190,"The FDA has detennined that such clearance or approval is not necessary .","{The,FDA,has,detennined,that,such,clearance,or,approval,is,not,necessary,.}","{the,FDA,have,detennine,that,such,clearance,or,approval,be,not,necessary,.}","{DT,NNP,VBZ,VBN,IN,JJ,NN,CC,NN,VBZ,RB,JJ,.}","{2,4,4,0,12,7,12,0,12,12,12,4,0}","{}"
